Literature DB >> 16737823

The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Subramaniam Malarkannan1.   

Abstract

NK cells use NKG2D receptor to recognize 'induced-self'. In apparent violation of the 'missing-self' hypothesis, NK cells stimulated through NKG2D can lyse target cells despite normal expression levels of MHC class I molecules. Although, 'overriding' of the inhibitory by the activating signals had been postulated the precise role of inhibitory Ly49 receptors on NKG2D-mediated activation has only started emerging. We propose that NKG2D-mediated activation is a function of 'altering the balance' in the signaling strength between the activating NKG2D and inhibiting Ly49 receptors. Balance in the signaling strength depends on the expression levels of activating ligands on the target cells. Qualitative and quantitative variations of MHC class I molecules expressed on the target cells also plays a major role in determining this 'altered-balance'. Consequently, the nature of Ly49 receptors expressed on specific NK subsets determines the level of NKG2D-mediated NK cell activation. These observations provide a firm basis of 'altered-balance' in NK signaling and describe an active interplay between inhibitory Ly49 and activating NKG2D receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737823      PMCID: PMC2752866          DOI: 10.1016/j.smim.2006.04.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  75 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

Review 2.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors.

Authors:  Lorenzo Moretta; Alessandro Moretta
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

3.  Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b).

Authors:  Julie Dam; Rongjin Guan; Kannan Natarajan; Nazzareno Dimasi; Lukasz K Chlewicki; David M Kranz; Peter Schuck; David H Margulies; Roy A Mariuzza
Journal:  Nat Immunol       Date:  2003-11-02       Impact factor: 25.606

4.  Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

Authors:  V Groh; S Bahram; S Bauer; A Herman; M Beauchamp; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.

Authors:  B A Binstadt; K M Brumbaugh; C J Dick; A M Scharenberg; B L Williams; M Colonna; L L Lanier; J P Kinet; R T Abraham; P J Leibson
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

Review 6.  The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?

Authors:  A M Scharenberg; J P Kinet
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

7.  Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.

Authors:  W Held; D Cado; D H Raulet
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

Review 8.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

9.  Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

Authors:  James R Carlyle; Amanda M Jamieson; Stephan Gasser; Christopher S Clingan; Hisashi Arase; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

10.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.

Authors:  H G Ljunggren; K Kärre
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

Review 2.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Authors:  Lei Shi; Kang Li; Yizhan Guo; Anirban Banerjee; Qing Wang; Ulrike M Lorenz; Mahmut Parlak; Lucy C Sullivan; Oscar Okwudiri Onyema; Saeed Arefanian; Edward B Stelow; David L Brautigan; Timothy N J Bullock; Michael G Brown; Alexander Sasha Krupnick
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-31       Impact factor: 11.205

Review 4.  Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy.

Authors:  Kamalakannan Rajasekaran; Matthew J Riese; Sridhar Rao; Li Wang; Monica S Thakar; Charles L Sentman; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2016-05-12       Impact factor: 7.561

Review 5.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

6.  IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection.

Authors:  Pawan Kumar; Kamalakannan Rajasekaran; Arash Nanbakhsh; Jack Gorski; Monica S Thakar; Subramaniam Malarkannan
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

7.  Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation.

Authors:  Emily C Suter; Eva M Schmid; Andrew R Harris; Erik Voets; Brian Francica; Daniel A Fletcher
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

Review 8.  Regulation of ligands for the activating receptor NKG2D.

Authors:  Anita R Mistry; Chris A O'Callaghan
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

9.  Creation of the two isoforms of rodent NKG2D was driven by a B1 retrotransposon insertion.

Authors:  C Benjamin Lai; Ying Zhang; Sally L Rogers; Dixie L Mager
Journal:  Nucleic Acids Res       Date:  2009-03-20       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.